APA (7th ed.) Citation

TJ, W., CM, L., J, M., RT, G., N, L., A, L., . . . Fox, L. (2012). A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256. Journal of Infectious Diseases, 206(4), 534. https://doi.org/10.1093/infdis/jis376

Chicago Style (17th ed.) Citation

TJ, Wilkin, et al. "A Pilot Trial of Adding Maraviroc to Suppressive Antiretroviral Therapy for Suboptimal CD4⁺ T-cell Recovery Despite Sustained Virologic Suppression: ACTG A5256." Journal of Infectious Diseases 206, no. 4 (2012): 534. https://doi.org/10.1093/infdis/jis376.

MLA (9th ed.) Citation

TJ, Wilkin, et al. "A Pilot Trial of Adding Maraviroc to Suppressive Antiretroviral Therapy for Suboptimal CD4⁺ T-cell Recovery Despite Sustained Virologic Suppression: ACTG A5256." Journal of Infectious Diseases, vol. 206, no. 4, 2012, p. 534, https://doi.org/10.1093/infdis/jis376.